NATIONAL INTERGROUP 7.8% STAKE IN SYSTEMED MAY BE SPRINGBOARD
Executive Summary
NATIONAL INTERGROUP 7.8% STAKE IN SYSTEMED MAY BE SPRINGBOARD for a possible acquisition of the pharmacy benefit management firm by the FoxMeyer parent corporation. In an Aug. 5 13D filing with the Securities & Exchange Commission, National Intergroup says it believes that SysteMed "is presently undervalued" and that it "may determine to seek control" of SysteMed. FoxMeyer pointed out Aug. 12 that National Intergroup has numerous investments that are not geared towards acquisitions. The 13D language is intended to preserve all options, FoxMeyer said.